| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.07 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.43 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |